Our findings support the beneficial use of plasma copeptin measurement in prognostication following stroke, thus indicating that a biomarker-based approach with the evaluation of copeptin may provide important insight into the recovery potential of each stroke survivor and significantly facilitate individualized stroke care. Here, AVP is linked to stroke disorder.